Table 5. Characteristics of head and neck cancer patients in high-cetuximab and low-cetuximab use hospitals (n = 611).
| High-use (n = 313) | Low-use (n = 298) | P-value | |
| n(%) | n(%) | ||
| Age,yr (Mean±SD) | 59±12 | 56±11 | 0.002 |
| Male gender | 302(96) | 285(96) | 0.590 |
| Charlson Comorbidity Index Score | 0.082 | ||
 1 |
145(46) | 159(53) | |
| Socioeconomic status | 0.840 | ||
High (NT$20001 or  US$626) |
81(26) | 75(25) | |
| Urbanization level | 0.094 | ||
| Rural | 109(35) | 85(29) | |
| Region of residence | <0.001 | ||
| Southern/Eastern | 104(33) | 21(7) | |
| Treatment | 0.028 | ||
| Chemotherapy/Chemotherapy+Radiotherapy | 158(51) | 124(42) |
*
Parenthesis is percentage of patients in high-use or low-use hospitals.